title: Reply to M. Perier-Muzet et al.
authors.affiliation: University Hospital, University Duisburg-Essen, Germany lisa.zimmer@uk-essen.de.
authors.forename: Lisa
authors.initials: L
authors.lastname: Zimmer
authors.affiliation: Melanoma Institute Australia; and The University of Sydney, Sydney, Australia.
authors.forename: Lauren E
authors.initials: LE
authors.lastname: Haydu
authors.affiliation: Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia.
authors.forename: Alexander M
authors.initials: AM
authors.lastname: Menzies
authors.affiliation: Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia.
authors.forename: Richard A
authors.initials: RA
authors.lastname: Scolyer
authors.affiliation: Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia.
authors.forename: Richard F
authors.initials: RF
authors.lastname: Kefford
authors.affiliation: Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia.
authors.forename: John F
authors.initials: JF
authors.lastname: Thompson
authors.affiliation: University Hospital, University Duisburg-Essen, Germany.
authors.forename: Dirk
authors.initials: D
authors.lastname: Schadendorf
authors.affiliation: Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia.
authors.forename: Georgina V
authors.initials: GV
authors.lastname: Long
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000453:epidemiology*; D016609:Neoplasms, Second Primary / Q000453:epidemiology*; D012878:Skin Neoplasms / Q000453:epidemiology*